C0085315||Cerebral toxoplasmosis
C0001175||acquired immune deficiency syndrome
C0562508||neurological emergency department
C0337954||tertiary hospital
C0085315||Cerebral toxoplasmosis
C1883067||space
C0221505||brain lesion
C0006137||Brazil
C2603343||study
C0150093||case series
C0011900||diagnosed
C0085315||cerebral toxoplasmosis
C0203860||brain imaging
C0007806||cerebrospinal fluid
C0936012||analyzed
C0085315||Cerebral toxoplasmosis
C0011900||diagnosis
C3714514||infection
C0019682||human immunodeficiency virus
C0019682||human immunodeficiency virus
C0019699||HIV seropositive
C0011900||diagnosis
C0085315||cerebral toxoplasmosis
C0700287||reported
C1963724||antiretroviral therapy
C0199176||prophylaxis
C0085315||toxoplasmosis
C0018681||Headache
C1457887||strength deficit
C0015967||fever
C0037088||signs and symptoms
C2603343||study
C0085315||toxoplasmosis
C0040405||CT
C0024485||MRI
C1292530||CSF samples
C1446409||positive
C0022885||indirect haemagglutination test
C0370074||Toxoplasma gondii IgG
C0014441||ELISA
C1446409||positive
C0022885||direct haemagglutination test
C1708063||first-line treatment
C0085315||toxoplasmosis
C0085315||Cerebral toxoplasmosis
C0027765||neurological disease
C0237401||individuals
C0001175||AIDS
C0184666||admitted
C0027855||neurology
C0562508||emergency departments
C0596473||Early diagnosis
C0749647||empiric treatment
C1963724||antiretroviral therapy
C0033325||prognosis